Tesla Stock Pops as Elon Musk Promises DOGE Draw Back
Tesla reported a sharp drop in first-quarter earnings and sales, as the EV maker suffered a backlash to its CEO's political ambitions.


Tesla (TSLA) stock is soaring Wednesday as investors cheer CEO Elon Musk's promises that he will step back from his responsibilities at the Department of Government Efficiency (DOGE).
Musk's pledge offset the company's dismal first-quarter earnings report, which came in much lower than analysts expected.
For the three months ending March 31, Tesla said earnings plunged 40% year over year to 27 cents per share while revenue slumped 9% to $19.3 billion.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Analysts expected the company to report earnings of 42 cents per share on revenue of $21.5 billion.
Sales and earnings results followed the release of the electric vehicle company's delivery numbers earlier this month. Tesla produced 345,454 vehicles and delivered 323,800 vehicles, representing year-over-year declines of 16% and 12%, respectively.
Tesla also said it is "difficult to measure the impacts of shifting global trade policy on the automotive and energy supply chains, our cost structure and demand for durable goods and related services." Management will revisit its full-year guidance in Q2.
As for the positives in Tesla's earnings report, CFRA Research analyst Garrett Nelson points to the company's assurance that "it remains on track for the pilot launch of robotaxi in Austin by June."
Tesla also said "it plans to build the Optimus robot on the Fremont pilot production line in 2025," while Cybercap production is expected to begin next year, Nelson adds.
Musk talks DOGE in the Tesla earnings call
It's been a rough stretch for Tesla shareholders, with the stock down 41% for the year to date through the April 22 close.
"The company has become a political lightning rod," explains Steve Sosnick, chief strategist at Interactive Brokers, "thanks to Elon Musk's key role at the Department of Government Efficiency."
Sosnick goes on to say that a major element of Tesla is its futurism, with hopes for robotaxis, robotics and other inventions playing an integral role in its rich valuation.
And having "a visionary who is busy with the day-to-day mechanics of government bureaucracy is highly unlikely to be simultaneously making concrete progress toward those corporate goals," he adds.
But in Tesla's earnings call, CEO Elon Musk said that in the next month or so, his time at DOGE will "drop significantly" to one or two days each week.
As for the Trump administration's trade policies, Musk noted that Tesla is "the least affected car company with respect to tariffs, at least in most respects," though he admitted that "tariffs are still tough on a company when margins are still low."
For what it's worth, Tesla's operating margin came in at 2.1% for the first quarter, down from 5.5% the year prior, due to lower auto deliveries and higher costs related to its artificial intelligence (AI) initiatives.
Is Tesla stock a buy, hold or sell today?
Wall Street is currently on the sidelines when it comes to the consumer discretionary stock.
Of the 48 analysts covering TSLA who are tracked by S&P Global Market Intelligence, 16 say it's a Strong Buy, seven call it a Buy, 14 rate it a Hold and 11 have it at Sell or Strong Sell. This works out to a consensus Hold recommendation.
Oppenheimer analyst Colin Rusch is one of those with a Perform (Hold) rating on Tesla stock.
Rusch says that while he believes Tesla "has the potential to be a transformational technology company and deliver outsized returns," it's currently in "show-me territory with investors" given its long history of "promises and delays" on its various initiatives.
As such, he remains cautious on the shares.
Related content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
How to Access Your Parents’ Medicare to Help them Enroll and Manage Their Care
Getting access to your parents' Medicare or Medicare Advantage accounts is easiest when they're healthy. But you still have options if they are incapacitated.
By Donna LeValley
-
Don't Veer Off Course at the First Sign of a Squall in the Markets
When markets go nuts and investor sentiment drops, you can keep your sanity by trusting in and sticking with your long-term plan.
By James Martielli, CFA®, CAIA®
-
Don't Veer Off Course at the First Sign of a Squall in the Markets
When markets go nuts and investor sentiment drops, you can keep your sanity by trusting in and sticking with your long-term plan.
By James Martielli, CFA®, CAIA®
-
How Business Owners Can Prepare for a Terminal Diagnosis
The most important thing is readiness, whether the owner faces a life-changing diagnosis or an employee does.
By H. Dennis Beaver, Esq.
-
Advisers, Take Note: How 2025 Social Security Changes May Impact Your Clients
What financial advisers might need to know to help their clients navigate Social Security in 2025.
By Jake Klima
-
Stock Market Today: Have We Seen the Bottom for Stocks?
Solid first-quarter earnings suggest fundamentals remain solid, and recent price action is encouraging too.
By David Dittman
-
Social Security Is Taxable, But There Are Workarounds
If you're strategic about your retirement account withdrawals, you can potentially minimize the taxes you'll pay on your Social Security benefits.
By Todd Talbot, CFP®, NSSA, CTS™
-
Serious Medical Diagnosis? Four Financial Steps to Take
A serious medical diagnosis calls for updates of your financial, health care and estate plans as well as open conversations with those who'll fulfill your wishes.
By Thomas C. West, CLU®, ChFC®, AIF®
-
What Wall Street's CEOs Are Saying About Trump's Tariffs
We're in the thick of earnings season and corporate America has plenty to say about the Trump administration's trade policy.
By Karee Venema
-
To Stay on Track for Retirement, Consider Doing This
Writing down your retirement and income plan in an investment policy statement can help you resist letting a bear market upend your retirement.
By Matt Green, Investment Adviser Representative